A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Huang, Hui ^a   Wang, Yan xun ^a   Jiang, Chun guo ^a   Liu, Jia ^a   Li, Ji ^a   Xu, Kai ^a   Xu, Zuo jun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

ANCA; Pulmonary fibrosis; Systemic vasculitis

Indexed keywords

ADULT; AGED; CHINA; FEMALE; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES;

EID: 84892920654     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-8     Document Type: Article

References (19)

1. Niles JL, Böttinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996, 156:440-445. 10.1001/archinte.1996.00440040118013, 8607730.
2. Chung SA, Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am 2010, 36:545-558. 10.1016/j.rdc.2010.04.003, 2917831, 20688249.
3. Eschun GM, Mink SN, Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003, 123:297-301. 10.1378/chest.123.1.297, 12527637.
4. Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP, Brauner M, Nicaise P, Cadranel J, Cottin V, Tazi A, Aubier M, Crestani B. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008, 102:1392-1398. 10.1016/j.rmed.2008.04.023, 18640019.
5. Hervier B, Pagnoux C, Agard C, Haroche J, Amoura Z, Guillevin L, Hamidou MA, French Vasculitis Study Group Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009, 68:404-407. 10.1136/ard.2008.096131, 18957485, French Vasculitis Study Group.
6. Nozu T, Kondo M, Suzuki K, Tamaoki J, Nagai A. A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 2009, 77:407-415. 10.1159/000183754, 19077381.
7. Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, Moutsopoulos HM. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010, 36:116-121. 10.1183/09031936.00110109, 19926741.
8. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
9. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824. 10.1164/rccm.2009-040GL, 21471066, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis.
10. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary renal vasculitis in elderly patients. Mayo Clin Proc 1990, 65:847-856. 10.1016/S0025-6196(12)62575-0, 2195245.
11. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 2004, 9:190-196. 10.1111/j.1440-1843.2004.00581.x, 15182268.
12. Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 2011, 50:2035-2043. 10.1093/rheumatology/ker236, 21873269.
13. Colby TV, Fukuoka J, Ewaskow SP, Helmers R, Leslie KO. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol 2001, 5:309-319. 10.1053/adpa.2001.27923, 11598860.
14. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL. Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J 1999, 14:118-124. 10.1034/j.1399-3003.1999.14a20.x, 10489838.
15. Al Riyami BM, Al Kaabi JK, Elagib EM, El Khatim HS, Woodhouse NJ. Subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome. Clin Rheumatol 2003, 22:309-313. 10.1007/s10067-003-0738-x, 14579162.
16. Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyangiitis presenting as a " pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?. Arthritis Rheum 2007, 56:2065-2071. 10.1002/art.22633, 17530647.
17. Foucher P, Heeringa P, Petersen AH, Huitema MG, Brouwer E, Tervaert JW, Prop J, Camus P, Weening JJ, Kallenberg CG. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 1999, 160:987-994. 10.1164/ajrccm.160.3.9807139, 10471629.
18. Han F, Liu G, Zhang X, Li X, He Q, He X, Li Q, Wang S, Wang H, Chen J. Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis. Am J Nephrol 2011, 33:185-192. 10.1159/000324364, 21311184.
19. Roll P, Ostermeier E, Haubitz M, Lovric S, Unger L, Holle J, Kötter I, Henes JC, Bergner R, Rubbert-Roth A, Specker C, Schulze-Koops H, Müller-Ladner U, Fleck M, Burmester GR, Hiepe F, Heitmann S, Aringer M, Fischer-Betz R, Dörner T, Tony HP. Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID). J Rheumatol 2012, 39:2153-2156. 10.3899/jrheum.120482, 22984269.